Sign in
WithdrawnNo phase

A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence

Key facts

Who runs it
University of Rochester
Where
Rochester, United StatesSee the site
Trial code
Status
Withdrawn
Started
29 Oct 2021
Ended
4 Aug 2025
Type of study
Interventional
Treatments tested
  • High-Dose-Rate Brachytherapy
Record updated
15 October 2025
Why it stopped
study stopped early, did not enroll anyone, and will not resume

Who can take part

Age
18 years and older
Sex
Men only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • History of histologically confirmed, clinically localized adenocarcinoma of the prostate treated with external beam radiation, brachytherapy, or combination of external beam radiation and brachytherapy, with curative intent completed at least 24 months ago F-18 fluciclovine (AXUMIN) PET scan within 90 days prior to registration demonstrating recurrent lesion within the prostate gland Biopsy confirmation of disease recurrence within the prostate gland Age ≥ 18 KPS ≥ 70% Suitable candidate for brachytherapy based on established criteria IPSS score <16 No pelvic arch interference No Rectal fistula/fissure Fit for general or spinal anesthesia No history of urethral stricture Ability to understand, and willingness to sign the written informed consent

Who cannot take part

  • Evidence of metastatic or nodal disease outside of the prostate gland on AXUMIN PET scan within 90 days prior to enrollment Patient unable to have MRI Patients with neuroendocrine or small cell carcinoma of the prostate TURP within 6 months prior to enrollment History of Crohn's disease, ulcerative colitis, or known radiation proctitis Inability to understand spoken and written English

Where in United States

  • University of RochesterRochester, United States

About the trial

What the trial wants to find out

The purpose of this study is to learn more about what effects the use of high-dose-rate (HDR) brachytherapy on prostate cancer recurrence, seen by AXUMIN PET scan, has on prostate cancer.

The group in the trial

  • Experimental: High-Dose-Rate prostate brachytherapyTreatment being tested

    High-Dose-Rate brachytherapy, 2 fractions

    Treatment: High-Dose-Rate Brachytherapy

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
A Pilot Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence
Record updated
15 October 2025